Abstract
Hyperlipidemia represents a spectrum of metabolic disorders, the manifestation of which includes an elevation of plasma cholesterol, triglyceride, or both above accepted normal limits. Primary lipid disorders are hereditary in nature, however, a number of plasma lipid disorders are secondary to an endocrine or nutritional imbalance or other disease processes. Although we allude to elevated cholesterol and/or triglycerides in plasma as criteria of defective lipid metabolism, a true understanding of the metabolic defects must reside in our understanding of the metabolism of the complex macromolecules which transport combinations of these lipids—i.e., the plasma lipoproteins. In the last decade we have learned a great deal about the synthesis, transport and catabolism of the various components of the lipoproteins. A completely integrated metabolic map is far from complete and in this review we will attempt to present a series of logical concepts which are supported by experimental data derived from experiments in man and other animals. At times we may indulge in speculation about possible mechanisms in areas where data are contradictory or missing. Unfortunately, few mechanisms seem fixed at the present time; instead they represent hypotheses based on limited data.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Abramson, E. A., Arky, R. A.: Acute antilipolytic effects of ethyl alcohol and acetate in man. J. Lab. clin. Med. 72, 105–117 (1968).
Alaupovic, P., Sanbar, S.S., Furman, R.H., Sullivan, M. L., Walraven, S.L.: Studies of the composition and structure of serum lipoproteins. Isolation and characterization of very high density lipoproteins of human serum. Biochemistry 5, 4014–4053 (1966).
Alaupovic, P.: Conceptual development of the classification systems of plasma lipoproteins. In: Peeters, H. (Ed.) Proceedings of the XIX Annual Colloquium of the Protides of Biological Fluids. New York: Pergamon Press 1972.
Albers, J.J., Aladjem, F.: Precipitation of 125I-labeled lipoproteins with specific polypeptide antisera. Evidence for two populations with differing polypeptide compositions in human high density lipoproteins. Biochemistry 10, 3436–3442 (1971).
Albrink, M. J., Lavietes, P. H., Mann, E. B.: Vascular disease and serum lipids in diabetes mellitus. Ann. intern. Med. 58, 305–323 (1963).
Anderson, N. G., Fawcett, B.: An antichylomicronemic substance produced by heparin injection. Proc. Soc. exp. Biol. (N.Y.) 74, 768–771 (1950).
Bacon, G. E., Sanbar, S. S.: Serum lipids and lipoproteins in diabetic children. Univ. Mich. Med. Centr. J. 34, 84–87 (1968).
Bagdade, J.D., Porte, D., Jr., Bierman, E. L.: Acute insulin withdrawal and the regulation of plasma triglyceride removal in diabetic subjects. Diabetes 17, 127–132 (1968a).
Bagdade, J.D., Porte, D., Jr., Bierman, E. L.: Hypertriglyceridemia. A metabolic consequence of chronic renal failure. New Engl. J. Med. 279, 181–185 (1968b).
Bagnall, T. F.: Composition of low density lipoprotein in children with familial hyperbetalipoproteinemia and the effect of treatment. Clin. chim. Acta 42, 229–233 (1972).
Barter, P.J., Nestel, P. J., Carroll, K. F.: Precursors of plasma triglyceride fatty acid in humans. Effects of glucose consumption, clofibrate administration, and alcoholic fatty liver. Metabolism 21, 117–124 (1972).
Barter, P. J., Nestel, P.J.: Precursors of plasma triglyceride fatty acids in obesity. Metabolism 22, 779–785 (1973).
Baxter, J. H., Goodman, H. C., Havel, R.J.: Serum lipid and lipoprotein alterations in nephrosis. J. clin. Invest. 39, 455–465 (1960).
Bezman, A., Felts, J. M., Havel, R.J.: Relation between incorporation of triglyceride fatty acids and heparin-released lipoprotein lipase from adipose tissue slices. J. Lipid Res. 3, 427–431 (1962).
Bezman-Tarcher, A., Nestel, P.J., Felts, J. M., Havel, R.J.: Metabolism of hepatic and plasma triglycerides in rabbits given ethanol or ethionine. J. Lipid Res. 7, 248–257 (1966).
Bier, D. M., Havel, R.J.: Activation of lipoprotein lipase by lipoprotein fractions of human serum. J. Lipid Res. 11, 565–570 (1970).
Bierman, E. L., Bagdade, J.D., Porte, D., Jr.: A concept of the pathogenesis of diabetic lipemia. Trans. Ass. Amer. Physicns 79, 348–360 (1966).
Biggs, M.W.: Studies on exogenous cholesterol metabolism in human atherosclerosis with the aid of isotopes. Advanc. Biol. med. Physics 5, 357–384 (1957).
Bilheimer, D. W., Eisenberg, S., Levy, R. I.: The metabolism of very low density lipoprotein proteins. 1. Preliminary in vitro and in vivo observations. Biochim. biophys. Acta (Amst.) 260, 212–221 (1972).
Buberg, J., Carlson, L.A., Normell, L.: Production of lipolytic activity by the isolated, perfused dog liver in response to heparin. Life Sci. 3, 1011–1019 (1964).
Borensztajn, J., Robinson, D. S.: The effect of fasting on the utilization of chylomicron triglyceride fatty acids in relation to clearing factor lipase (lipoprotein lipase) releasable by heparin in the perfused rat heart. J. Lipid Res. 11, 111–117 (1970).
Borrie, P.: Type III hyperlipoproteinemia. Brit. med. J. 11, 665–667 1969.
Braun, G. A., Marsh, J. B., Drabkin, D.L.: Stimulation of protein and plasma albumin synthesis in a cellfree system from livers of nephrotic rats. Biochem. Res. Commun. 8, 28–32 (1962).
Brown, D. F., Daudiss, K.: Hyperlipoproteinemia prevalence in a free living population in Albany, New York. Circulation 47, 558–566 (1973).
Brown, M. S., Dana, S. E., Goldstein, J. L.: Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts by lipoproteins. Proc. nat. Acad. Sci. (Wash.) 70, 2162–2166 (1973).
Brown, M. S., Dana, S. E., Goldstein, J. L.: Regulation of 3-hydroxy-3-methylglutaryl coenzmye A reductase activity in cultured human fibroblasts comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J. biol. Chem. 249, 789–796 (1974).
Brown, M. S., Goldstein, J. L.: Expression of the familial hypercholesterolemia gene in hetero-zygotes: mechanism for a dominant disorder in man. Science 185, 61–63 (1974).
Brown, H. B., Lewis, L.A., Page, I. H.: Mixed hyperlipemia, a sixth type of hyperlipoproteinemia. Atherosclerosis 17, 181–196 (1974).
Burstein, M., Samaille, J.: Sur un dosage rapide du cholesterol lie aux α-et aux β-lipoproteines du serum. Clin. chim. Acta 5, 609 (1960).
Camejo, G., Bosch, V., Arreaza, C., Mendez, H. C.: Early changes in plasma lipoprotein structure and biosynthesis in cholesterol-fed rabbits. J. Lipid Res. 14, 61–68 (1973).
Carlson, L.A.: Clinical aspects of classification of primary hyperlipoproteinemias. In: Human Hyperlipoproteinemias Principles and Methods. Fumagalli, R., Ricci, G., Gorini, S. (Eds.) Advanc. exp. Med. Biol. 38, 89–104 (1973).
Cornwell, D. G., Kruger, F. A.: Molecular complexes in isolation and characterization of plasma lipoproteins. J. Lipid Res. 2, 110–134 (1961).
Crepaldi, G., Fellin, R., Tiengo, A.: Hyperlipoproteinemias and endocrine diseases. In: Fuma-Galli, R., Riccl, G., Gorini, S. (Eds.): Human Hyperlipoproteinemias Principles and Methods. Advanc. Exp. Med. Biol. 38, 113–132 (1973).
Crouse, J. R., Gerson, C. D., DE Carli, L. M., Lieber, C. S.: Role of acetate in the reduction of plasma free fatty acids produced by ethanol in man. J. Lipid Res. 9, 509–512 (1968).
del Gatto, L., Lindgren, E. T., Nichols, A. V.: Ultracentrifugal methods for the determination of serum lipoproteins. Anal. Chem. 31, 1397–1399 (1959).
de Lalla, O., Gofman, J.: Ultracentrifugal analysis of serum lipoproteins. Methods Biochem. Anal. 1, 459–478 (1954).
de Lalla, O. F., Tandy, R. K., Loeb, H. G.: A simplified method for the analysis of ultracentri fuge film records of low density lipoproteins of human serum. Clin. Chem. 13, 85–100 (1967).
Dietschy, J.M.: The role of bile salts in controlling the rate of intestinal cholesterogenesis. J. clin. Invest. 47, 286–300 (1968).
Dietschy, J.M., Wilson, J.D.: Cholesterol synthesis in the squirrel monkey: relative rates of synthesis in various tissues and mechanisms of control. J. clin. Invest. 47, 166–174 (1968).
Dietschy, J.M., Wilson, J.M.: Regulation of cholesterol metabolism. New Engl. J. Med. 282, 1179–1183 (1970).
Dole, V.P.: A relation between non-esterified fatty acids in plasma and the metabolism of glucose. J. clin. Invest. 35, 150–154 (1956).
Dole, V. P., Hamlin, J. T. III: Particulate fat in lymph and blood. Physiol. Rev. 42, 674–701 (1962).
Durrum, E. L., Paul, M. H., Smith, E. R. B.: Lipid detection in paper electrophoresis. Science 116, 428–430 (1952).
Eisenberg, S., Bilheimer, D. W., Levy, R. I.: The metabolism of very low density lipoprotein proteins. II. Studies on the transfer of apoproteins between plasma lipoproteins. Biochim. biophys. Acta (Amst.) 280, 94–104 (1972).
Eisenberg, S., Bilheimer, D. W., Levy, R.I., Lindgren, F. T.: On the metabolic conversion of human plasma very low density lipoprotein to low density lipoprotein. Biochim. biophys. Acta (Amst.) 326, 361–377 (1973).
Engelberg, H.: In vitro studies of human plasma lipolytic activity before and after oral fat intake. J. appl. Physiol. 11, 155–160 (1957).
Ewing, A. M., Freeman, N. K., Lindgren, F. T.: The analysis of human serum lipoprotein distributions. Advanc. Lipid Res. 3, 25–61 (1965).
Fasoli, A.: Electrophoresis of serum lipoproteins of filter paper. Lancet 1, 106 1952.
Felts, J.M.: The metabolism of chylomicron triglyceride fatty acids by perfused rat livers and by intact rats. Ann. N.Y. Acad. Sci. 131, 24–33 (1965).
Felts, J.M., Mayes, P.A.: Lack of uptake and oxidation of chylomicron triglyceride to carbon dioxide and ketone bodies by the perfused rat liver. Nature (Lond.) 206, 195–196 (1965).
Fisher, W.R., Hammond, M. G., Warmke, G.L.: Measurements of the molecular weight variability of plasma low density lipoproteins among normals and subjects with hyper-13-lipoproteinernia. Demonstration of macromolecular heterogeneity. Biochemistry 11, 519–525 (1972).
Forte, G.M., Maims, A.V., Glaeser, R.M.: Electron microscopy of human serum lipoproteins using negative staining. Chem. Phys. Lipids 2, 396–408 (1968).
Fredrickson, D. S., Ono, K., Dams, L. L.: Lipolytic activity of postheparin plasma in hyperglyceridemia. J. Lipid Res. 4, 24–33 (1963).
Fredrickson, D. S., Lees, R. S.: System for phenotyping hyperlipoproteinemia. Circulation 31, 321–327 (1965).
Fredrickson, D. S., Levy, R. I., Lees, R. S.: Fat transport in lipoproteins—an integrated approach to mechanisms and disorders. New Engl. J. Med. 276, 32–44 (1967).
Fredrickson, D. S., Levy, R. I.: Familial hyperlipoproteinemia. In: Stanbury, J. B., Wyngaarden, J.B., Fredrickson, D.B. (Eds.): The Metabolic Basis of Inherited Disease. New York: McGraw-Hill 1972.
Fredricxson, D. S., Lux, S. E., Herbert, P. N.: The apolipoproteins. Advanc. exp. Med. Biol. 26, 25–56 (1972).
Garfinkel, A.S., Schotz, M. C.: Separation of molecular species of lipoprotein lipase from adipose tissue. J. Lipid Res. 13, 63–8 (1972).
Giltin, D., Cornwell, D. G., Nakasato, D., Oncley, J.L., Hughes, W. L., Jr., Janeway, C. A.: Studies on the metabolism of plasma proteins in the nephrotic syndrome. II. The lipoproteins. J. clin. Invest. 37, 172–184 (1958).
Glomset, J. A., Norum, K.R.: The metabolic role of lecithin: cholesterol acyltransferase: perspectives from pathology. Advanc. Lipid. Res. 11, 11–65 (1973).
Glueck, C. J., Levy, R. I., Glueck, H. I., Gralnick, H. R., Greten, H., Fredrickson, D. S.: Acquired Type I hyperlipoproteinemia with systemic lupus erythematosus, dysglobulinemia, and heparin resistance. Amer. J. Med. 47, 318–324 (1969a).
Glueck, C.J., Levy, R. I., Fredrickson, D.S.:Immunoreactive insulin, glucose tolerance, and carbohydrate inducibility in Types II, III, IV, and V hyperlipoproteinemia. Diabetes 18, 739–747 (1969b).
Glueck, C. J., Heckman, F., Schoenfeld, M., Steiner, P., Pearce, W.: Neonatal familial Tape II hyperlipoproteinemia; cord blood cholesterol in 1800 live births. Metabolism 20, 597–608 (1971).
Glueck, C. J., Tsang, R. C.: Neonatal familial Type II hyperlipoproteinemia: Effects of diet on plasma cholesterol in the first year of life. Amer. J. clin. Nutr. 25, 224–230 (1972).
Gofman, J.W., Rubin, L., Mcginley, J.P., Jones, H. B.: Hyperlipoproteinemia. Amer. J. Med. 17, 514–520 (1954).
Goldstein, J.L., Brown, M. S.: Familial hypercholesterolemia identification of a defect in the regulation of 3-hydroxy-3-methyl glutaryl coenzyme. A reductase activity associated with over production of cholesterol. Proc. nat. Acad. Sci. (Wash.) 70, 2804–2808 (1973).
Goldstein, J. L., Schrott, H. G., Hazzard, W. R., Bierman, E. L., Motulsky, A. G.: Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J. clin. Invest. 52, 1544–1568 (1973).
Goodman, D. S.: The metabolism of chylomicron cholesterol ester in the rat. J. clin. Invest. 41, 1886–1896 (1962).
Goustos, A., Felts, J. M., Havel, R.J.: The metabolism of serum triglycerides and free fatty acids by the myocardium. Metabolism 12, 75–80 (1963).
Hahn, P.F.: Abolishment of alimentary lipemia following injection of heparin. Science 98, 19–20 (1943).
Hamilton, R. L.: Postheparin plasma lipase from the hepatic circulation. Dissertation Abs. 26, 24 (1965).
Harlan, W.R., Jr., Graham, J. B., Estes, E.H.: Familial hypercholesterolemia: a genetic and metabolic study. Medicine 45, 77–110 (1966).
Harlan, W. R., Winesett, P. S., Wasserman, A. J.: Tissue lipoprotein lipase in normal individuals and in individuals with exogenous hypertriglyceridemia and the relationship of this enzyme to assimilation of fat. J. clin. Invest. 46, 239–247 (1967).
Harris, K., Felts, J. M.: Kinetics of chylomicron triglyceride removal from plasma in rats: the effect of diet. Biochim. biophys. Acta (Amst.) 316, 288–295 (1973).
Hatch, F. T., Lees, R. S.: Practical methods for plasma lipoprotein analysis. Advanc. Lipid Res. 6, 1–68 (1968).
Havel, R.J., Eder, H.A., Bragdon, J.H.: The distribution and chemical composition of ultra-centrifugally separated lipoproteins in human serum. J. clin. Invest. 34, 1345–1353 (1955).
Havel, R.J., Gordon, R. S., Jr.: Idiopathic hyperlipemia: metabolic studies in an affected family. J. clin. Invest. 39, 1777–1790 (1960).
Havel, R.J., Felts, J. M., van Duyne, C.M.: Formation and fate of endogenous triglycerides in blood plasma of rabbits. Lipid Res. 3, 297–308 (1962).
Havel, R.J., Shore, V. G., Shore, B., Bier, D. M.: Role of specific glycopeptides of human serum lipoproteins in the activation of lipoprotein lipase. Circulation Res. 27, 595–600 (1970).
Havel, R. J.: Mechanisms of hyperlipoproteinemia. Advanc. exp. Biol. 26, 57–70 (1972).
Havel, R.J., Kane, J. P.: Primary dysbetalipoproteinemia: a predominance of a specific apoprotein species in triglyceride-rich lipoproteins. Proc. nat. Acad. Sci. (Wash.) 70, 2015–2019 (1973).
Havel, R. J., Kane, J.P., Kasityap, M.L.: Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man. J. clin. Invest. 52, 32–38 (1973).
Hazzard, W.R., Lindgren, F. T., Bierman, E. L.: Very low density lipoprotein subfractions in a subject with broad-β disease (Type III hyperlipoproteinemia) and a subject with endogenous lipemia (Type IV). Chemical composition and electrophoretic mobility. Biochim. biophys. Acta (Amst.) 202, 517–525 (1970a).
Hazzard, W. R., Porte, D., Jr., Bierman, E. L.: Abnormal lipid composition of chylomicrons in broad-β disease (Type III hyperlipoproteinemia). J. clin. Invest. 49, 1853–1858 (1970b).
Hazzard, W. R., Goldstein, J. L., Schrott, H. G., Motulsky, A. G., Bierman, E. L.: Hyperlipidemia in coronary heart disease. III. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction. J. clin. Invest. 52, 1569–1577 (1973).
Herbert, P.N., Forte, T. M., Schulman, R. S., Gong, E. L., Lapiana, M. J., Nichols, A. V., Levy, R.I., Fredrickson, D. S.: Selective loss of apolipoproteins upon ultracentrifugation of very low density lipoproteins (VLDL). Federation Proc. 32, 548 (1973).
Hillyard, L.A., Cornelius, C. E., Chaikoff, I. L.: Removal by the isolated rat liver of palmitate-1-C14 bound to albumin and of palmitate-1-C14 and cholesterol-4-C14 in chylomicrons from perfusion fluid. J. biol. Chem. 234, 2240–2245 (1959).
Huang, T. C., Kuksis, A.: A comparative study of the lipids of chylomicron membrane and fat core and of the lymph serum of dogs. Lipids 2, 443–452 (1967).
Jeffries, G. H.: The effect of fat absorption on the interaction of chyle and plasma in the rat. Quart. J. exp. Physiol. 39, 77–81 (1954).
Kalab, M., Martin, W. G.: Gel filtration of native and modified pig serum lipoproteins. J. Chromatogr. 35, 230–233 (1968).
Kessler, J. I., Stein, J., Dannacker, D., Narcessian, P.:Biosynthesis of low density lipoprotein by cell-free preparations of rat intestinal mucosa. J. biol. Chem. 245, 5281–5288 (1970).
Khoo, J. C., Steinberg, D., Thompson, B., Mayer, S. E.: Hormone regulation of adipocyte enzymes. J. biol. Chem. 248, 3823–3830 (1973).
Killander, J., Bengtsson, S., Philipson, L.: Fractionation of human plasma macroglobulins by gel filtration on pearl-condensed agar. Proc. Soc. exp. Biol. (N.Y.) 115, 861–865 (1964).
Klatskin, G., Gordon, M.: Relationship between relapsing pancreatitis and essential hyperlipemia. Am. J. Med. 12, 3–23 (1952).
Koppers, L. E., Palumbo, P. J.: Lipid disturbances in endocrine disorders. Med. Clin. N. Am. 56, 1013–1020 (1972).
Korn, E.D.: Clearing factor, a heparin-activated lipoprotein lipase. I. Isolation and characterization of the enzyme from normal rat heart. J. biol. Chem. 215, 1–14 (1955a).
Korn, E.D.: Clearing factor, a heparin-activated lipoprotein lipase. II. Substrate specificity and activation of coconut oil. J. biol. Chem. 215, 15–26 (1955b).
Korn, E.D.: The assay of lipoprotein lipase in vivo and in vitro. Methods Biochem. Anal. 7, 145–192 (1959).
Krauss, R. M., Windmueller, H. G., Levy, R. I., Fredrickson, D. S.: Selective measurement of two different triglyceride lipase activities in rat postheparin plasma. J. Lipid Res. 14, 286–295 (1973).
Kritchevsky, D., Tepper, S.A., Alaupovic, P., Furman, R.H.: Cholesterol content of human serum lipoproteins obtained by dextran sulfate precipitation and by preparative ultracentrifugation. Proc. Soc. exp. Biol. (N.Y.) 112, 259–262 (1963).
Kwitterovich, P. O., Levy, R.I., Fredrickson, D. S.: Early detection and treatment of familial Type II hyperlipoproteinemia. Circulation 42, 111–11 (1970).
Langer, T., Strober, W., Levy, R.I.:The metabolism of low density lipoprotein in familial Type II hyperlipoproteinemia. J. clin. Invest. 51, 1528–1536 (1972).
Larosa, J. C., Levy, R.I., Herbert, P., Lux, S. E., Fredrickson, D. S.: A specific apoprotein activator for lipoprotein lipase. Biochem. Biophys. Res. Commun. 41, 57–62 (1970).
Lee, G. B., Culley, G. A., Lawson, M. J., Adcock, L. L., Krivit, W.: Type II hyperlipoproteinemia in mother and twins. Circulation 39, 183–188 (1969).
Lees, R. S., Hatch, F. T.: Sharper separation of lipoprotein species by paper electrophoresis in albumin-containing buffer. J. Lab. clin. Med. 61, 518–528 (1963).
Lees, R. S., Wilson, D. E., Schonfeld, G., Fleet, S.: The familial dyslipoproteinemias. Prog. Med. Genet. 9, 237–290 (1973).
Levy, R. I., Quarfordt, S.H., Brown, W. V., Sloan, H.R., Fredrickson, D.S.: The efficacy of clofibrate (CP1B) in familial hyperlipoproteinemias. In: Holmes, W. L., Carlson, L.A., Paoletti, R. (Eds.): Drugs Affecting Lipid Metabolism. New York: Plenum 1969.
Levy, R. I., Lees, R. S., Fredrickson, D. S.: The nature of pre-beta (very low density) lipoproteins. J. clin. Invest. 45, 63–77 (1965).
Levy, R. I., Fredrickson, D. S.: The current status of hypolipidemic drugs. Postgrad. Med. 47, 130–136 (1970).
Lewis, L. A., Page, I. H.: Electrophoretic and ultracentrifugal analysis of serum lipoproteins of normal, nephrotic, and hypertensive persons. Circulation 7, 707–717 (1953).
Lewis, L. A., Zuehlke, V., Nakamoto, S., Kolff, W. J., Page, I. H.: Renal regulations of serum a-lipoproteins. Decrease of a-lipoproteins in the absence of renal function. New Engl. J. Med. 275, 1097–1105 (1966).
Lewis, B., Chait, A., Stssons, P.: Lipid abnormalities in alcoholism and chronic renal failure. Advanc. exp. Med. Biol. 38, 155–159 (1973).
Lindgren, F.T., Maims, A.V.: Structure and function of human serum lipoproteins. In: Put-Man, F. W. (Ed.): Plasma Proteins. New York: Academic Press 1960.
Lossow, W. J., Naidoo, S. S., Chaikoff, I. L.: Effect of heparin on disappearance of the cholesterol moiety of an injected cholesterol-C14-labeled, very low density chyle lipoprotein fraction from the circulation of the rat. J. Lipid Res. 4, 419–423 (1963).
Margolis, S.: Separation and size determination of human serum lipoproteins by agarose gel filtration. J. Lipid Res. 8, 501–507 (1967).
Marsh, J. B., Whereat, A. F.: The synthesis of plasma lipoprotein by rat liver. J. biol. Chem. 234, 3196–3200 (1959).
Masoro, E. J., Chaikoff, I. L., Chernick, S. S., Felts, J. M.: Previous nutritional state and glucose conversion to fatty acids in liver slices. J. biol. Chem. 185, 845–856 (1950).
Masoro, E.J., Felts, J. M.: Role of carbohydrate metabolism in promoting fatty acid oxidation. J. biol. Chem. 231, 347–356 (1958).
Masoro, E.J.: Biochemical mechanisms related to the homeostatic regulation of lipogenesis in animals. J. Lipid Res. 3, 149–164 (1962).
Mayer, J.: Metabolism of the adipose tissue in the hereditary obese-hyperglycemic syndrome. In: Rodahl, K., Issekutz, B. (Eds.): Fat as a Tissue. New York: McGraw-Hill 1964.
Mayes, P.A., Felts, J. M.: Lack of uptake and metabolism of the triglyceride of serum lipoproteins of density less than 1.006 by the perfused rat liver. Biochem. J. 105, 180–200 (1967).
Mayes, P. A., Felts, J. M.: The functional status of lipoprotein lipase in rat liver. Biochem. J. 108, 483–487 (1968).
Minari, O., Zilversmit, D. B.: Behavior of dog lymph chylomicron lipid constituents during incubation with serum. J. Lipid Res. 4, 424–436 (1963).
Morris, M. D., Chaikoff, I. L.: The origin of cholesterol in liver, small intestine, adrenal gland, and testis of the rat: dietary versus endogenous contributions. J. biol. Chem. 234, 1095–1097 (1959).
Naito, C., Felts, J. M.: Influence of heparin on the removal of serum lipoprotein lipase by the perfused liver of the rat. J. Lipid Res. 11, 48–53 (1970).
Nestel, P. J., Havel, R. J., Bezman, A.: Metabolism of constituent lipids of dog chylomicrons. J. clin. Invest. 42, 1313–1321 (1963).
Nestel, P. J., Whyte, H.M.: Plasma free fatty acid and triglyceride turnover in obesity. Metabolism 17, 112–118 (1968).
Nikkila, N.A.: Metabolic typing of hypertriglyceridemia. Scand. J. clin. Lab. Invest. 29, 126–331 (1972).
Noble, R. P.: Electrophoretic separation of plasma lipoproteins in agarose gel. J. Lipid Res. 9, 693–700 (1968).
Ockner, R.K., Hughes, F.B., Isselbacher, K.J.: Very low density lipoproteins in intestinal lymph: role in triglyceride and cholesterol transport during fat absorption. J. clin. Invest. 48, 2367–2373 (1969).
Olivecrona, T., Egelrud, T.: Evidence for an ionic binding of lipoprotein lipase to heparin. Biochem. Biophys. Res. Commun. 43, 524–529 (1971).
Paula, R. K., Rudel, L.L.: Influence of dietary cholesterol on plasma lipoprotein structure and distribution in Macaca nemestrina. Circulation 49, 50, 111–269 (1974).
Pollard, H., Scanu, A.M., Taylor, E.W.: On the geometrical arrangement of the protein subunits of human serum low density lipoprotein: evidence for a dodecahedral model. Proc. nat. Acad. Sci. (Wash.) 64, 304–310 (1969).
Porte, D., O’hara, D. D., Williams, R. H.: The relationship between postheparin lipolytic activity and plasma triglyceride in myxedema. Metabolism 15, 107–113 (1966).
Quarfordt, S. H., Goodman, D. S.: Chylomicron cholesteryl ester metabolism in the perfused rat liver. Biochim. Biophys. Acta (Amst.) 176, 863–872 (1969).
Quarfordt, S., Levy, R.I., Fredrickson, D. S.: On the lipoprotein abnormality in Type III hyperlipoproteinemia. J. clin. Invest. 50, 754–761 (1971).
Quarfordt, S., Nathans, A., Dowdee, M., Hilderman, H. L.: Heterogeneity O f human very low density lipoproteins by gel filtration chromatography. J. Lipid Res. 13, 435–444 (1972).
Rachmilewitz, D., Stein, O., Roheim, P.S., Stein, Y.: Metabolism of iodinated high density lipoproteins in the rat. II. Autoradiographic localization in the liver. Biochim. biophys. Acta (Amst.) 270, 414–425 (1972).
Radding, C. M., Steinberg, D.: Studies on the synthesis and secretion on serum lipoproteins by rat liver slices. J. clin. Invest. 39, 1560–1569 (1960).
Redgrave, T. B.: Formation of cholesteryl ester-rich particulate lipid during metabolism of chylomicrons. J. clin. Invest. 49, 465–471 (1970).
Robinson, D. S., Jeffries, G. H., French, J. E.: Studies on the interaction of chyle and plasma in the rat. Quart. J. exp. Physiol. 39, 165–176 (1954).
Robinson, D. S., Jeffries, G. H., Poole, J.C.F.: Further studies on the interaction of chyle and plasma in the rat. Quart. J. exp. Physiol. 40, 297–308 (1955).
Robinson, D. S., Harris, P.M.: The production of lipolytic activity in the circulation of the hind limb in response to heparin. Quart. J. exp. Physiol. 44, 80–90 (1959).
Robinson, D. S.: The function of the plasma triglycerides in fatty acid transport. In: Florkin, M., Stotz, E. H. (Eds.): Comprehensive Biochemistry. New York: Elsevier Publishing Company 1970.
Roheim, P. S., Haft, D. E., Gidez, L. I., White, A., Eder, H.A.: Plasma lipoprotein metabolism in perfused rat livers. II. Transfer of free and esterified cholesterol into the plasma. J. clin. Invest. 42, 1277–1285 (1963).
Rose, H.G., Kranz, P., Weinstock, M., Juliano, J., Haft, J. I.: Inheritance of combined hyperlipoproteinemia: Evidence for a new lipoprotein phenotype. Amer. J. Med. 54, 148–159 (1973).
Rose, H.G., Kranz, P., Weinstock, M., Juliano, J., Haft, J. Combined hyperlipoproteinemia—evidence for a new lipoprotein phenotype. Atherosclerosis 20, 51–64 (1974).
Rudel, L.L., Morris, M.D., Felts, J. M.: The transport of exogenous cholesterol in the rabbit. I. Role of cholesterol ester of lymph chylomicra and lymph very low density lipoproteins in absorption. J. clin. Invest. 51, 2686–2692 (1972).
Rudel, L. L., Mitamura, T., Felts, J. M.: Characterization of rabbit lymph chylomicra and very low density lipoproteins. Circulation 47, 48, 7–252 (1973a).
Rudel, L.L., Felts, J. M., Morris, M. D.: Exogenous cholesterol transport in rabbit plasma lipoproteins. Biochem. J. 134, 531–537 (1973b).
Rudel, L.L., Lee, J. A., Morris, M. D., Felts, J. M.: Characterization of plasma lipoproteins separated and purified by agarose-column chromatography. Biochem. J. 139, 89–95 (1974).
Rudel, L.L., Lofland, H.B., Jr.: Circulating lipoproteins in nonhuman primates. In: Strong, J. P. (Ed.): Atherosclerosis in Primates. New York: Karger. In Press.
Salans, L.B., Knittle, J.L., Hirsch, J.: The role of adipose cell size and adipose tissue insulin sensitivity in carbohydrate intolerance of human obesity. J. clin. Invest. 47, 153–165 (1968).
Sata, T., Estrich, D.L., Wood, P.D. S., Kinsell, L.W.: Evaluation of gel chromatography for plasma lipoprotein fractionation. J. Lipid Res. 11, 331–340 (1970).
Sata, T., Havel, R.J., Jones, A.L.: Characterization of subfractions of triglyceride-rich lipoproteins separated by gel chromatography from blood plasma of normolipemic and hyperlipemic humans. J. Lipid Res. 13, 757–768 (1972).
Scanu, A.M., Granda, J.L.: Effects of ultracentrifugation of the human serum high density (1.063 < d < 1.21 g/ml) lipoprotein. Biochemistry 5, 446–454 (1966).
Schreibman, P.H., Arons, D.L., Saudek, C.D., Arky, R.A.:Abnormal lipoprotein lipase in familial exogenous hypertriglyceridemia. J. clin. Invest. 52, 2075–2082 (1973).
Schumaker, V. N., Adams, G. H.: Circulating lipoproteins. Ann. Rev. Biochem. 38, 113–136 (1969).
Scott, P. J., Hurley, P.J.: Effect of clofibrate on low density lipoprotein turnover in essential hypercholesterolaemia. J. Atheroscler. Res. 9, 25–34 (1969).
Shefer, S., Hauser, S., Lapar, V., Mosbach, E.H.: Regulatory effects of sterols and bile acids on hypercholesterolemia. J. Atheroscler. Res. 9, 25–34 (1969).
Shefer, S., Hauser, S., Lapar, V., Mosbach, E.H.: Regulatory effects of sterols and bile acids on hypercholesterolemia. J. Lipid Res. 14, 573–580 (1973).
Shipp, J.C., Wood, F. C., Jr., Marble, A.: Hyperlipemia following sulfonylurea therapy in young diabetics. J. Amer. med. Ass. 188, 468–471 (1964).
Shore, V. G., Shore, B.: Heterogeneity of human plasma very low density lipoproteins. Separation of species differing in protein components. Biochemistry 12, 502–507 (1973).
Shore, V.G., Shore, B., Hart, R.G.: Changes in apolipoproteins and properties of rabbit very low density lipoproteins on induction of cholesteremia. Biochemistry 13, 1579–1584 (1974).
Skipski, V. P.: Lipid composition of lipoproteins in normal and diseased states. In: Nelson, G. J., (Ed.): Blood Lipids and Lipoproteins: Quantitation, Composition, and Metabolism. New York: Wiley-Interscience 1972.
Slack, J., Nevin, N. C.: Hyperlipidaemic xanthomatosis. I. Increased risk of death from ischaemic heart disease in first degree relatives of 53 patients with essential hyperlipidaemia and xanthomatosis. J. med. Genet. 5, 4–28 (1968).
Slack, J., Mills, G. L.: Anomalous low density lipoproteins in familial hyperbetalipoproteinemia. Clin. chim Acta 29, 15–25 (1970).
Smith, E. B.: Lipoprotein patterns in myocardial infarction. Lancet 11, 910–914 1957.
Steinberg, D.: Hormonal control of lipolysis in adipose tissue. Advanc. Exp. med. Biol. 26, 77–88 (1972).
Steiner, G.: Lipoprotein lipase in fat induced hyperlipidemia. New Engl. J. Med. 279, 70–74 (1968).
Stone, N., Levy, R., Fredrickson, D., Verter, J.: Coronary artery disease in familial Type II hyperlipoproteinemia: Study of 116 kindreds. Third International Symposium on Atherosclerosis, Berlin 1973. Schettler, G., Schlierf, G. (Eds.). Berlin: Karger, In Press.
Treadwell, C.R., Swell, L., Vahouny, G.V., Field, H., Jr.: Observations on the mechanism of cholesterol absorption. J. Amer. Oil chem. Soc. 36, 107–111 (1958).
Tytgat, G. N., Rubin, C. E., Aunders, D. R.: Synthesis and transport of lipoprotein particles by intestinal absorptive cells in man. J. clin. Invest. 50, 2065–2078 (1971).
Werner, M.: Fractionation of lipoproteins from blood by gel filtration. J. Chromatogr. 25, 63–70 (1966).
Wfayne, T.F., Jr., Felts, J.M., Harris, P.A.: Effect of heparin on the inactivation of serum lipoprotein lipase by the liver in unanesthetized dogs. J. clin. Invest. 48, 1246–1251 (1969).
Whayne, T. F., Jr., Felts, J.M.: Activation of lipoprotein lipase. Comparative study of man and other mammals. Circulation Res. 26, 545–551(1970a).
Whayne, T.F., Jr., Felts, J.M.: Activation of lipoprotein lipase. Effects of rat serum lipoprotein fractions and heparin. Circulation Res. 27, 941–951 (1970b).
Windmueller, H.G., Lindgren, F. T., Lossow, W.J., Levy, R.I.: On the nature of circulating lipoproteins of intestinal origin in the rat. Biochim. biophys. Acta (Amst.) 202, 507–516 (1970).
Windmueller, H.G., Herbert, P.N., Levy, R.I.: Biosynthesis of lymph and plasma lipoprotein apoproteins by isolated perfused rat liver and intestine. J. Lipid Res. 14, 215–223 (1973).
Yoshitoshi, Y., Naito, C., Okaniwa, H., Usut, M., Mogami, T., Tomono, T.: Kinetic Studies On metabolism of lipoprotein lipase. J. clin. Invest. 42, 707–713 (1963).
Zelis, R., Mason, D.T., Braunwald, E., Levy, R.I.: Effects of hyperlipoproteinemias and their treatment on the peripheral circulation. J. clin. Invest. 49, 1007–1015 (1970).
Zilversmit, D. B.: The composition and structure of lymph chylomicrons in dog, rat, and man. J. clin. Invest. 44, 1610–1622 (1965).
Zilversmit, D. B.: The surface coat of chylomicrons: lipid chemistry. J. Lipid Res. 9, 180–186 (1968).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Felts, J.M., Rudel, L.L. (1975). Mechanisms of Hyperlipidemia. In: Kritchevsky, D. (eds) Hypolipidemic Agents. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 41. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66190-7_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-66190-7_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-66192-1
Online ISBN: 978-3-642-66190-7
eBook Packages: Springer Book Archive